Inhibition of the development of the hepatic stages of Plasmodium yoelii nigeriensis by antihistaminic agents.
Singh
N
N
Division of Microbiology, Central Drug Research Institute, Lucknow, India.
Puri
S K
SK
D000818:Animals; D000962:Antimalarials / Q000627:therapeutic use*; D003533:Cyproheptadine / Q000627:therapeutic use; D004305:Dose-Response Relationship, Drug; D005260:Female; D006634:Histamine H1 Antagonists / Q000627:therapeutic use*; D007665:Ketotifen / Q000627:therapeutic use; D008099:Liver / Q000469:parasitology; D008288:Malaria / Q000517:prevention & control*; D008297:Male; D051379:Mice; D010967:Plasmodium yoelii / Q000187:drug effects* / Q000254:growth & development
D000962:Antimalarials; D006634:Histamine H1 Antagonists; D003533:Cyproheptadine; D007665:Ketotifen